Evaluation of the Roche SARS-CoV-2 Rapid Antibody Test in samples from vaccinated individuals
Johannes Hayer, Eva Urlaub
doi: https://doi.org/10.1101/2021.12.17.21267927
Johannes Hayer
1Roche Diagnostics GmbH, Mannheim, Germany
Eva Urlaub
1Roche Diagnostics GmbH, Mannheim, Germany
Article usage
Posted April 06, 2022.
Evaluation of the Roche SARS-CoV-2 Rapid Antibody Test in samples from vaccinated individuals
Johannes Hayer, Eva Urlaub
medRxiv 2021.12.17.21267927; doi: https://doi.org/10.1101/2021.12.17.21267927
Subject Area
Subject Areas
- Addiction Medicine (371)
- Allergy and Immunology (689)
- Anesthesia (184)
- Cardiovascular Medicine (2748)
- Dermatology (235)
- Emergency Medicine (414)
- Epidemiology (12400)
- Forensic Medicine (10)
- Gastroenterology (784)
- Genetic and Genomic Medicine (4261)
- Geriatric Medicine (396)
- Health Economics (699)
- Health Informatics (2757)
- Health Policy (1018)
- Hematology (369)
- HIV/AIDS (879)
- Medical Education (404)
- Medical Ethics (112)
- Nephrology (453)
- Neurology (4037)
- Nursing (216)
- Nutrition (599)
- Oncology (2127)
- Ophthalmology (604)
- Orthopedics (251)
- Otolaryngology (312)
- Pain Medicine (256)
- Palliative Medicine (77)
- Pathology (478)
- Pediatrics (1148)
- Primary Care Research (470)
- Public and Global Health (6653)
- Radiology and Imaging (1446)
- Respiratory Medicine (886)
- Rheumatology (421)
- Sports Medicine (353)
- Surgery (464)
- Toxicology (57)
- Transplantation (192)
- Urology (171)